Biotech / Medical: AMLN (DIABETES DRUGS)
Posts: 2173 | Member SubjectMarks: 74 | No Bans

Add SubjectMark | Show Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: eric siegel -- (Not Moderated) -- Started: 5/18/1996 2:07:00 AM  Revision History

Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
2173bydureon approved. ugly, ugly experience. scaram(o)uche-01/27/2012 02:34 PM
2172Thank goodness we have some sort of closure. I wonder what Carl is thinking. Herichardred-11/08/2011 12:46 PM
2171Lilly-Amylin’s Diabetes Drug Wins Approval for Expanded Use richardred-10/20/2011 12:55 AM
2170AMLN says - accusing the larger drugmaker of breaking their commercialization detom pope-05/16/2011 12:46 PM
2169Amylin's Goal: Get Lilly to buy them out? I don't quite understand therkrw-05/16/2011 11:22 AM
2168AP: THE COMPLAINT: Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit atom pope-05/16/2011 11:15 AM
2167>Two or three months for a pop or drop.< Actually, neither. A “recommendaDewDiligence_on_SI-04/17/2011 11:11 PM
2166Two or three months for a pop or drop. European committee endorses Bydureon frichardred-04/17/2011 09:20 PM
2165And the XOMA P2B trial in type 2 diabetes fails: [graphic]Message 27256483 Chetuck-03/22/2011 06:42 PM
2164Amylin and Takeda have suspended the Symlin/metreleptin obesity study due to an tuck-03/16/2011 12:46 PM
2163Today's failure of Bydureon against Victoza led me to dig into the Takeda obtuck-03/03/2011 02:45 PM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2013 Knight Sac Media. All rights reserved.